MedTrace Logo

SkinPen Efficacy on Acne Scars on the Face and/or Back

NCT02646917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2021-07-21

Study results available
· View outcomes & findings →

Summary

This single-center, clinical trial will take place over a 90 day course followed by 1-month and 6-month post treatment visits to assess the efficacy and tolerability of the SkinPen device when used on both men and women on the face and/or back.

Conditions

  • Atrophic Acne Scar

Interventions

PROCEDURE

Aesthetic Microneedling Treatment

Treatment of acne scars on the face and/or back at needle depth settings ranging between 0.25 mm to 2.0 mm, depending on severity and location of scarring.

Sponsors & Collaborators

  • Bellus Medical, LLC

    lead INDUSTRY

Principal Investigators

  • Thomas J Stephens, Ph.D · Thomas J. Stephens & Associates, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-31
Completion
2017-07-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02646917 on ClinicalTrials.gov